Skip to main content

ICYMI 2021 Rheumatology Year In Review

Jul 08, 2022 2:48 pm
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021. My Top 10 list 1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod 2. New FDA Indications 3. New Biologics for Lupus 4. Super "H" Hydroxychloroquine 5. Zoomatology 6. Avacopan 7. Tocilizumab 8. FDA & JAK inhibitor warnings 9. New Biologics for GCA 10. IL-23 Inhibitors

Add new comment

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.